Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Current assets:
Cash and cash equivalents	$ 107,839	$ 117,453
Prepaid expenses	1,421	2,142
Total current assets	109,260	119,595
Property and equipment, net	4,890	4,612
Operating lease right-of-use assets	1,159	0
Total assets	115,309	124,207
Current liabilities:
Accounts payable	1,265	1,080
Related party payable	140	126
Accrued expenses	2,101	1,434
Operating lease liability, current portion	650
Total current liabilities	4,156	2,640
Operating lease liability, net current portion	509	0
Total liabilities	4,665	2,640
Commitments and contingencies (Note 10)
Stockholders' equity / members' deficit:
Preferred stock, $0.0001 par value - 20,000 shares authorized; none issued and outstanding as of March 31, 2022
Additional Paid in Capital	67,933	55,737
Accumulated deficit	(14,554)	(8,331)
Total stockholders' equity attributable to Rani Therapeutics Holdings, Inc.	53,384	47,411
Non-controlling interest	57,260	74,156
Total stockholders' equity	110,644	121,567
Total liabilities and stockholders' equity	115,309	124,207
Common Class A [Member]
Stockholders' equity / members' deficit:
Common stock, value	2	2
Common Class B [Member]
Stockholders' equity / members' deficit:
Common stock, value	3	3
Common Class C [Member]
Stockholders' equity / members' deficit:
Common stock, value		$ 0